We use cookies on this website. By continuing to use this site without changing your cookie settings, you agree that you are happy to accept our cookies and for us to access these on your device. Find out more about how we use cookies and how to change your cookie settings.

Sir Paul Nurse to head UK Centre for Medical Research and Innovation

15 July 2010

Nobel laureate Sir Paul Nurse is to become the first Director and Chief Executive of the UK Centre for Medical Research and Innovation (UKCMRI), planned for central London. For the past two years, he has been chairing the UKCMRI Scientific Planning Committee, which has been advising on the Centre’s development. He will take up his post on 1 January 2011.

UKCMRI has been founded by four of the UK's largest and most successful scientific and academic institutions: the Medical Research Council, Cancer Research UK, the Wellcome Trust and University College London. It will carry out research of the highest quality using the latest technology to advance understanding of human health and disease. The project represents a substantial investment from charity and public funders in the future growth of one of the UK's leading sectors.

Sir Paul Nurse said: "I am honoured to have the opportunity to head UKCMRI as it takes shape as one of the foremost biomedical research institutes in the world. This is a time of extraordinary opportunity in our quest to understand the causes of health and disease. UKCMRI will have a key role in developing our understanding and ability to tackle many of the most significant diseases that affect people and their families."

A Nobel Prize-winning biologist, Sir Paul has been elected the next President of the Royal Society. He is currently President of the Rockefeller University, New York, which he joined in 2003.

Before moving to the USA, Sir Paul spent more than three decades working in the UK, where he was born. He was Director General of the Imperial Cancer Research Fund and played a major role in its merger with the Cancer Research Campaign, forming Cancer Research UK - which he went on to lead as Chief Executive.

His research focuses on controls of cell division and cell shape in yeast. It led to the identification of cyclin-dependent kinases as the key molecules that regulate the process by which cells make copies of themselves, a discovery that is important for understanding growth, development and cancer.

He was awarded the Nobel Prize in Physiology or Medicine, which he shared with Tim Hunt and Lee Hartwell, in 2001 and was honoured with a knighthood for services to cancer research and cell biology in 1999.

Sir Mark Walport, Director of the Wellcome Trust, said: "Paul is an outstanding and inspirational research leader with exactly the vision and experience needed to position UKCMRI as a world-class centre for research. He will be crucial to realising the Centre's focus on turning fundamental discoveries about health and disease into new diagnostic, preventative and therapeutic strategies that directly benefit patients."

Image: Sir Paul Nurse

Share |
Home  >  News and features  >  2010  > Sir Paul Nurse to head UKCMRI
Wellcome Trust, Gibbs Building, 215 Euston Road, London NW1 2BE, UK T:+44 (0)20 7611 8888